These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38712794)

  • 21. Predisposing preventable factors in patients with bleeding due to warfarin usage: Evaluation of 114 patients.
    Beyan E; Beyan C; Vaizoğlu SA
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):684-7. PubMed ID: 19520686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge.
    Moffett BS; Kim S; Bomgaars LR
    Pediatr Blood Cancer; 2013 Sep; 60(9):1503-6. PubMed ID: 23606286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR.
    Sandén P; Renlund H; Svensson PJ; Själander A
    Thromb Haemost; 2017 Jan; 117(1):27-32. PubMed ID: 27652593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential interaction between telithromycin and warfarin.
    Kolilekas L; Anagnostopoulos GK; Lampaditis I; Eleftheriadis I
    Ann Pharmacother; 2004 Sep; 38(9):1424-7. PubMed ID: 15280511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults.
    Baillargeon J; Holmes HM; Lin YL; Raji MA; Sharma G; Kuo YF
    Am J Med; 2012 Feb; 125(2):183-9. PubMed ID: 22269622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Major Bleeding Among Working-Age Adults with Atrial Fibrillation: Evaluating the Effects of Potential Drug-drug Interactions and Switching from Warfarin to Non-vitamin K Oral Anticoagulants.
    Feng X; Sambamoorthi U; Innes K; Castelli G; LeMasters T; Xiong L; Williams MU; Tan X
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):591-600. PubMed ID: 30315487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levofloxacin-warfarin interaction.
    Gheno G; Cinetto L
    Eur J Clin Pharmacol; 2001 Aug; 57(5):427. PubMed ID: 11599661
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of oral diuretics on chronic warfarin therapy: a retrospective study.
    Edwards HD; Webb RD; Conway SE
    Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing warfarin-related bleeding.
    Glasheen JJ
    South Med J; 2005 Jan; 98(1):96-103. PubMed ID: 15678642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Warfarin users prone to coagulopathy in first 30 days after hospital discharge from gastric bypass.
    Bechtel P; Boorse R; Rovito P; Harrison TD; Hong J
    Obes Surg; 2013 Oct; 23(10):1515-9. PubMed ID: 23645479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Warfarin-associated bleeding events and concomitant use of potentially interacting medicines reported to the Norwegian spontaneous reporting system.
    Narum S; Solhaug V; Myhr K; Johansen PW; Brørs O; Kringen MK
    Br J Clin Pharmacol; 2011 Feb; 71(2):254-62. PubMed ID: 21219407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empiric warfarin dose adjustment with prednisone therapy. A randomized, controlled trial.
    Dowd MB; Vavra KA; Witt DM; Delate T; Martinez K
    J Thromb Thrombolysis; 2011 May; 31(4):472-7. PubMed ID: 21161329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety of levofloxacin in elderly patients on warfarin.
    Stroud LF; Mamdami MM; Kopp A; Bell CM
    Am J Med; 2005 Dec; 118(12):1417. PubMed ID: 16378802
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of warfarin was potentiated by an antitussive. Cocillana-Etyfin increased the PK(INR) value].
    Lövborg H; Jacobsson I; Hägg S
    Lakartidningen; 2009 Nov 4-12; 106(45):2968-9. PubMed ID: 19998819
    [No Abstract]   [Full Text] [Related]  

  • 35. Summaries for patients. Consequences of serious bleeding complications from warfarin.
    Ann Intern Med; 2003 Dec; 139(11):I22. PubMed ID: 14644906
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibiotic interactions: Answers to 4 common questions.
    Onysko M; Holcomb N; Hornecker J
    J Fam Pract; 2016 Jul; 65(7):442-8. PubMed ID: 27565097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries.
    Mosholder AD; Racoosin JA; Young S; Wernecke M; Shoaibi A; MaCurdy TE; Worrall C; Kelman JA
    Ann Pharmacother; 2013 Nov; 47(11):1420-8. PubMed ID: 24285759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between terbinafine and warfarin.
    Gupta AK; Ross GS
    Dermatology; 1998; 196(2):266-7. PubMed ID: 9568423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do children requiring long-term warfarin therapy present a bleeding risk during routine immunisation?
    Thursky EK; Eason AN; Blake EI; Kitson EM; Choy C; Nosworthy HS; Elia S; Newall F; Jones S
    Cardiol Young; 2016 Jan; 26(1):214-5. PubMed ID: 25915478
    [No Abstract]   [Full Text] [Related]  

  • 40. Retrospective assessment of potential interaction between levofloxacin and warfarin.
    Mercadal Orfila G; Gracia García B; Leiva Badosa E; Perayre Badía M; Reynaldo Martínez C; Jodar Masanés R
    Pharm World Sci; 2009 Apr; 31(2):224-9. PubMed ID: 19067226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.